Avenue Therapeutics, Inc. Profile Avatar - Palmy Investing

Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in…

Biotechnology
US, New York [HQ]

Lobbying Analysis

Avenue Therapeutics, Inc. has no lobbying expenses in our database.

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
No data
End of ATXI's Analysis
CIK: 1644963 CUSIP: 05360L205 ISIN: US05360L3042 LEI: - UEI: -
Secondary Listings
ATXI has no secondary listings inside our databases.